Sorafenib in Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Sorafenib in Advanced Hepatocellular Carcinoma

Published:2008-07-24 Issue:4 Volume:359 Page:378-390
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Llovet Josep M.,Ricci Sergio,Mazzaferro Vincenzo,Hilgard Philip,Gane Edward,Blanc Jean-Frédéric,de Oliveira Andre Cosme,Santoro Armando,Raoul Jean-Luc,Forner Alejandro,Schwartz Myron,Porta Camillo,Zeuzem Stefan,Bolondi Luigi,Greten Tim F.,Galle Peter R.,Seitz Jean-François,Borbath Ivan,Häussinger Dieter,Giannaris Tom,Shan Minghua,Moscovici Marius,Voliotis Dimitris,Bruix Jordi

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa0708857

Cited by 11196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benja-ummarit induces ferroptosis with cell ballooning feature through ROS and iron-dependent pathway in hepatocellular carcinoma;Journal of Ethnopharmacology;2024-12

2. MCM4 potentiates evasion of hepatocellular carcinoma from sorafenib-induced ferroptosis through Nrf2 signaling pathway;International Immunopharmacology;2024-12

3. Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1;Cellular Signalling;2024-12

4. Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma;European Journal of Medicinal Chemistry;2024-12

5. Systemic Therapies for Hepatocellular Carcinoma in India;Journal of Clinical and Experimental Hepatology;2024-11